Clinical Trials Directory

Trials / Completed

CompletedNCT02078011

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): A Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
David R. Brenin, MD · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test an investigational device called the Echopulse for treatment of breast fibroadenomas in women. Fibroadenomas are benign (noncancerous) breast tumors that are made of glandular and fibrous breast tissue. These lumps can occur alone, in groups, or as a complex of lumps together. Sometimes women feel these in the breast when doing regular self breast exams, or they may be found during a routine mammogram. Some are small (less than an inch in size), and others are quite large (the size of a lemon or larger). This is a study about the Echopulse device, a computer driven system which uses ultrasound to guide a high intensity focused ultrasound beam to a targeted area (the fibroadenoma in the breast). The high intensity focused ultrasound (HIFU) heats the targeted site which causes the cells to die and allows the possibility to treat the fibroadenoma without the need for surgery.

Conditions

Interventions

TypeNameDescription
DEVICEHigh Intensity Focused UltrasoundThe Echopulse device is a computer driven system which uses ultrasound to guide a high intensity focused ultrasound beam to a targeted area (the fibroadenoma in the breast).

Timeline

Start date
2014-04-01
Primary completion
2016-08-29
Completion
2017-10-01
First posted
2014-03-04
Last updated
2018-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02078011. Inclusion in this directory is not an endorsement.